RA Capital Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.6M | Hold |
2,538,925
| – | – | 0.68% | 28 |
|
|
2025
Q1 | $38.6M | Hold |
2,538,925
| – | – | 0.64% | 27 |
|
|
2024
Q4 | $51.5M | Hold |
2,538,925
| – | – | 0.69% | 30 |
|
|
2024
Q3 | $65.3M | Hold |
2,538,925
| – | – | 0.75% | 30 |
|
|
2024
Q2 | $32.7M | Buy |
+2,538,925
| New | +$32.7M | 0.43% | 45 |
|
|
2023
Q4 | – | Sell |
-240,324
| Closed | -$6.75M | – | 69 |
|
|
2023
Q3 | $6.75M | Buy |
240,324
+7,006
| +3% | +$197K | 0.13% | 59 |
|
|
2023
Q2 | $7.09M | Buy |
+233,318
| New | +$7.09M | 0.13% | 52 |
|